
| Developing HIV/AIDS Treatment Guidelines (UNAIDS, 1999, 43 p.) |
| Part 2: Developing valid HIV/AIDS guidelines |
![]() | Steps in developing HIV/AIDS treatment guidelines |
When deriving recommendations a criterion is required which, when consistently applied, links the evidence to the recommendations. Guidelines normally contain many different recommendations based upon varying levels of evidence. For further adaptation of guidelines at lower levels of the health care system, it is important that local protocol developers and their users are aware of the type of evidence used to make the recommendations. It is advisable that explicit links between guideline recommendations and the supporting evidence are described to ensure user confidence in their validity26.
The National Institutes of Health (NIH) of the United States of America have also developed guidelines for planning and managing consensus development conferences27. This approach begins with a broad-based nongovernmental panel, which is selected to meet in public to review data on a specified topic. Presentations are made by invited experts and the panel concentrates on responding to questions about the topic. At the close of the meeting they come up with an agreed statement which is widely publicized.
A method of grading recommendations according to the evidence used has been proposed by the United States AHCPR (Table 3). For example, a recommendation based upon the results of at least one randomized controlled trial would thus be based upon level 1b evidence and would be termed a "Grade A recommendation".
Table 3: Grading recommendations
|
Grade |
Recommendations (based on AHCPR 1994) |
|
A |
Requires at least one randomized control trial, as part of the body of literature of overall good quality and consistency, addressing the specific recommendations |
|
B |
Requires availability of well conducted clinical studies, but no randomized clinical trials on the topic of recommendation |
|
C |
Requires evidence from expert committee reports or opinions and/or clinical experience of respected authorities; it indicates the absence of directly applicable studies of good quality |
In the USPHS/IDSA HIV guidelines, a modified version of the categories suggested by PL Gross et al.28 has been used to reflect the quality and strength of each recommendation.